不孕症治療藥、設備市場:各類型，性別，各地區-規模，佔有率，展望，機會分析-2022～2028年

勃起功能障礙的盛行率增加，研究開發增加，新產品的認證，在市場活動的主要企業採用擴大策略，在預測期間內預計促進市場成長。

本報告提供全球不孕症治療藥、設備市場相關調查分析，市場促進因素，阻礙因素，市場機會，各類型、性別、地區市場分析，企業簡介相關資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

• 報告的說明
  • 市場定義和範圍
• 摘要整理
  • 市場明細:各類型
  • 市場明細:性別
  • 市場明細:各國
  • Coherent Opportunity Map(COM)

第3章 市場動態，法規，及趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 主要的焦點
• 產品銷售
• PEST分析
• 技術的進步
• 法規情境
• 合併和收購
• COVID-19對市場的影響

第4章 全球不孕症治療藥、設備市場:各類型(2017～2028年(100萬美元))

• 簡介
• 不孕症治療藥
• 不孕症設備

第5章 全球不孕症治療藥、設備市場:性別(2017～2028年(100萬美元))

• 簡介
• 男性
• 女性

第6章 全球不孕症治療藥、設備市場:各地區(2017～2028年(100萬美元))

• 簡介
• 北美
• 南美
• 歐洲
• 亞太地區
• 中東
• 非洲

第7章 競爭情形

• 企業簡介
  • Apricus Biosciences, Inc.
  • Bayer AG
  • Cristalia Produtos Quimicos Farmaceuticos Ltda.
  • Dong-A Pharmaceutical Co. Ltd.
  • Eli Lilly and Company
  • Meda Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • SK Chemicals Co. Ltd.
  • Vivus, Inc.
  • Mylan Pharmaceuticals Inc.
  • Ferring Pharmaceuticals
  • Cipla Ltd
  • Aspargo Laboratories, Inc.
  • Aurobindo Pharma Ltd.
  • Lupin Limited
  • Novartis International AG
  • Dare Bioscience, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Alembic Pharmaceuticals
  • Dr. Reddys Laboratories Ltd

第8章 Section

Infertility Drugs and Devices used for treating infertility in male and female. Factors such as endometriosis, ovarian disorders, uterine disorders, tubal disorders, and hormonal disorders are the major cause of female infertility, whereas male infertility is caused by azoospermia, varicocele, ejaculation disorders, and erectile dysfunction. Treatment procedure constitutes of drugs, Assisted Reproductive Technology (ART), surgery, artificial insemination, and in vitro fertilization. Increasing prevalence of erectile dysfunction, increasing research and development, new product approval, and adoption of expansion strategies from major players operating in the market is expected to propel the market growth during the forecast period.

Key features of the study:

• This report provides in-depth analysis of the Global Infertility Drugs and Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Infertility Drugs and Devices market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Apricus Biosciences, Inc., Bayer AG, Cristalia Produtos Quimicos Farmaceuticos Ltda., Dong-A Pharmaceutical Co. Ltd., Eli Lilly and Company, Meda Pharmaceuticals, Inc., Pfizer, Inc., S.K. Chemicals Co. Ltd., Vivus, Inc., Mylan Pharmaceuticals Inc., Ferring Pharmaceuticals, Cipla Ltd, Aspargo Laboratories, Inc., Aurobindo Pharma Ltd., Lupin Limited, Novartis International AG, Dare Bioscience, Inc., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals, and Dr. Reddys Laboratories Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Infertility Drugs and Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Infertility Drugs and Devices market

Detailed Segmentation:

• Global Infertility Drugs and Devices Market, By Type:
  • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
  • Infertility Devices
    • Equipment
    • Accessories
• Global Infertility Drugs and Devices Market, By Gender:
  • Male
  • Female
• Global Infertility Drugs and Devices Market, By Region:
  • North America
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Type:
    • Infertility Drugs
    • Clomiphene citrate
    • Sex hormones
    • Gonadotropins
    • Bromocriptine
    • Cabergoline
    • Imipramine
    • Letrozole
    • Metformin
    • Infertility Devices
    • Equipment
    • Accessories
    • By Gender
    • Male
    • Female
    • By Country
    • North Africa
    • Central Africa
    • South Africa
• Company Profiles
  • Apricus Biosciences, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bayer AG
  • Cristalia Produtos Quimicos Farmaceuticos Ltda.
  • Dong-A Pharmaceutical Co. Ltd.
  • Eli Lilly and Company
  • Meda Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • S.K. Chemicals Co. Ltd.
  • Vivus, Inc.
  • Mylan Pharmaceuticals Inc.
  • Ferring Pharmaceuticals
  • Cipla Ltd
  • Aspargo Laboratories, Inc.
  • Aurobindo Pharma Ltd.
  • Lupin Limited
  • Novartis International AG
  • Dare Bioscience, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Alembic Pharmaceuticals
  • Dr. Reddys Laboratories Ltd
• "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Gender
  • Market Snippet, By Country
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product launch
• PEST Analysis
• Technological Advancements
• Regulatory Scenario
• Mergers and Acquisitions
• Impact of COVID19 on market

4. Global Infertility Drugs and Devices Market, By Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Infertility Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Clomiphene citrate
  • Sex hormones
  • Gonadotropins
  • Bromocriptine
  • Cabergoline
  • Imipramine
  • Letrozole
  • Metformin
• Infertility Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Equipment
  • Accessories

5. Global Infertility Drugs and Devices Market, By Gender, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Infertility Drugs and Devices Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn))
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

7. Competitive Landscape

• Company Profiles
  • Apricus Biosciences, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bayer AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Cristalia Produtos Quimicos Farmaceuticos Ltda.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dong-A Pharmaceutical Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eli Lilly and Company
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Meda Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • S.K. Chemicals Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Vivus, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mylan Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Ferring Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Cipla Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aspargo Laboratories, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aurobindo Pharma Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lupin Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novartis International AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dare Bioscience, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Alembic Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dr. Reddys Laboratories Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact